Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Aratana Therapeutics shares drop after Stifel lowers pet medicine company to Hold

% of readers think this story is Fact. Add your two cents.


Shares of Aratana Therapeutics Inc (NASDAQ:PETX) fell Friday after Stifel Financial Corp (NYSE:SF) lowered the pet medicine developer to Hold from Buy and reduced his target for its shares to $5 from $8.

The company, according to Stifel analyst Jonathan Block, is seeing ongoing adoption of Entyce, its veterinary therapeutic medication that stimulates dogs’ appetite, but not much progress has been made on extending the drug’s duration, per a report on TheFly, the business news site.

Aratana shares slipped by 27% to hit $4.34 in Friday’s afternoon trading session.

READ: Genprex making strides to take cancer-fighting drug Oncoprex to FDA approval

Block cut his 2019-2024 Entyce estimates “materially.” His move to take a neutral stance on the stock is partly related to the Leawood, Kansas-based company’s “modest” drug pipeline and the recent departure of its chief operating officer.

Aratana boasts a trio of drugs – Entyce, Nocita, and Galliprant – that have all been approved by the Food and Drug Administration to treat pets.

Aratana CEO Steven St. Peter is particularly bullish on the prospects for Galliprant, an osteoarthritis pain reliever for dogs. 

“We are especially pleased with the strong performance of Galliprant, which in addition to gaining market share, also earned Aratana its first commercial milestone,” St. Peter said in a November statement delivered along with the company’s third-quarter results.

In the three months until the close of September, Aratana posted net sales of $21.6 million and net income of $8.8 million, or $0.19 per share. Net revenue for the third quarter included a $15 million commercial milestone, which drove profitability.

 

 

Story by ProactiveInvestors


Source: https://www.proactiveinvestors.com/companies/news/212427/aratana-therapeutics-shares-drop-after-stifel-lowers-pet-medicine-company-to-hold-212427.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)

Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen!

Nascent Iodine - Promotes detoxification, mental focus and thyroid health.

Smart Meter Cover -  Reduces Smart Meter radiation by 96%! (See Video).

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.